Alteration in plasma corticosterone levels following long term oral administration of lead produces depression like symptoms in rats

Metabolic Brain Disease

Volumn 28, Issue 1, 2013, Pages 85-92

  Haider, Saida ^a   Saleem, Sadia ^a   Tabassum, Saiqa ^a   Khaliq, Saima ^b   Shamim, Saima ^a   Batool, Zehra ^a   Parveen, Tahira ^a   Inam, Qurat Ul Ain ^a   Haleem, Darakhshan J ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

Corticosterone; Depression; Lead; Serotonin

Indexed keywords

CORTICOSTERONE; DRINKING WATER; LEAD ACETATE; SEROTONIN;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FOOD INTAKE; FORCED SWIMMING TEST; GROWTH RATE; LEAD POISONING; LOCOMOTION; LONG TERM EXPOSURE; MALE; NEUROTOXICITY; NONHUMAN; RAT; SEROTONIN BRAIN LEVEL;

ADMINISTRATION, ORAL; ANIMALS; BRAIN CHEMISTRY; CORTICOSTERONE; DEPRESSION; EATING; LEAD; MALE; MAZE LEARNING; RATS; RATS, WISTAR; SEROTONIN; SWIMMING;

RATTUS; RODENTIA;

EID: 84873408130     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9374-y     Document Type: Article

References (52)

1. Alam N, Haleem DJ, Najam R, Haider S, Ahmed SP (2011) Hypophagic and hypolocomotive effects of metachloro phenyl piperazine in rats treated with theophylline and caffeine. Pak J Pharm Sci 24(3):251-254
2. Arango V, Ernsberger P, Marzuk PM, Chen J, Tierney H, Stanley M, Reis DJ, Mann JJ (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatr 47(11):1038-1047
3. Badawy AA (1977) The functions and regulation of tryptophan pyrrolase. Life Sci 21:755-768
4. Badawy AA, Doughrty DM, Marsh-Richard DM, Steptoe A (2009) Activation of liver tryptophan Pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects. Alcohol Alcohol 44:267-271
5. Carroll BJ, Iranmanesh A, Keenan DM, Cassidy F, Wilson WH, Veldhuis JD (2012) Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr Scand 125:478-491
6. Cory-Slechta DA (1995) Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 35:391-415
7. Cory-Slechta DA, Virgolini MB, Thiruchelvam M, Weston DD, Bauter MR (2004) Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect 112:717-730
8. Cory-Slechta DA, Virgolini MB, Rossi-George A, Thiruchelvam M, Lisek R, Weston D (2008) Lifetime consequences of combined maternal lead and stress. Basic Clin Pharmacol Toxicol 102:218-227
9. Cory-Slechta DA, Stern S, Weston D, Allen JL, Liu S (2010) Enhanced learning deficits in female rats following lifetime pb exposure combined with prenatal stress. Toxicol Sci 117:427-438
10. de Souza Lisboa SF, Gonçalves G, Komatsu F, Queiroz CA, Almeida AA, Moreira EG (2005) Developmental lead exposure induces depressive-like behavior in female rats. Drug Chem Toxicol 28:67-77
11. Deakin JF, Pennell I, Upadhyaya AJ, Lofthouse R (1990) A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacol (Berl) 101:85-92
12. Donner NC, Montoya CD, Lukkes JL, Lowry CA (2012) Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinol 37:645-661
13. Dykeman R, Aguilar-Madrid G, Smith T, Juarez-Perez CA, Piacitelli GM, Hu H, Hernandez-Avila M (2002) Lead exposure in Mexican radiator repair workers. Am J Ind Med 41:179-187
14. Elias RW (1985) Lead exposure in the human environment. In: Mahaffy KR (ed) Dietary and environmental lead. Elsevier, Amsterdam, pp 79-107
15. Finkelstein Y, Markowitz ME, Rosen JF (1998) Low-level lead induced neurotoxicity in children: an update on central nervous system effects. Brain Res Brain Res Rev 27:168-176
16. Gasana J, Chamorro A (2002) Environmental lead contamination in Miami inner-city area. J Expo Anal Environ Epidemiol 12:265-272
17. Graham DL, Grace CE, Braun AA, Schaefer TL, Skelton MR, Tang PH, Vorhees CV, Williams MT (2011) Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats. Int J Dev Neurosci 29:45-55
18. Haider S, Shameem S, Ahmed SP, Perveen T, Haleem DJ (2005) Repeated administration of lead decreases brain 5-HT metabolism and produces memory deficits in rats. Cell Mol Biol Lett 10:669-676
19. Haider S, Tabassum S, Ali S, Saleem S, Khan AK, Haleem DJ (2011) Age-related decreases in striatal DA produces cognitive deficits in male rats. J Pharm Nutri Sci 1(1):20-27
20. Hammond PB, Succop PA (1995) Effects of supplemental nutrition on lead-induced depression of growth and food consumption in weanling rats. Toxicol Appl Pharmacol 131:80-84
21. Hammond PB, Minnema DJ, Succop PA (1993) Reversibility of lead-induced depression of growth. Toxicol Appl Pharmacol 123:9-15
22. Heisler LK, Zhou L, Bajwa P, Hsu J, Tecott LH (2007) Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 6:491-496
23. Hinkelmann K, Botzenhardt J, Muhtz C, Agorastos A, Wiedemann K, Kellner M, Otte C (2012) Sex differences of salivary cortisol secretion in patients with major depression. Stress 15:105-109
24. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30
25. Jokinen J, Nordström AL, Nordström P (2010) Cholesterol, CSF 5-HIAA, violence and intent in suicidal men. Psychiatr Res 178:217-219
26. Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, McInnis MG (2012) Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 136:350-358
27. Khaliq S, Haider S, Naqvi F, Perveen T, Saleem S, Haleem DJ (2012) Altered brain serotonergic neurotransmission following caffeine withdrawal produces behavioral deficits in rats. Pak J Pharm Sci 25:21-25
28. Kitamura Y, Araki H, Gomita Y (2002) Interaction of 5-HT and HPA axis in depression and treatment-resistant depression. Nihon Yakurigaku Zasshi 119:319-325
29. Kuhlmann AC, McGlothan JL, Guilarte TR (1997) Developmental lead exposure causes spatial learning deficits in adult rats. Neurosci Lett 233:101-104
30. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J (2002) Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect 110:721-728
31. Lidsky TI, Schneider JS (2003) Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126:5-19
32. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185
33. Mattingly D (1962) A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol 15:165-171
34. Meltzer H (1989) Serotonergic dysfunction in depression. Br J Psychiatr Suppl 8:25-31
35. Moberg T, Nordström P, Forslund K, Kristiansson M, Asberg M, Jokinen J (2011) CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. J Affect Disord 132:173-178
36. Moreira EG, Vassilieff I, Vassilieff VS (2001) Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol 23(5):489-495
37. Nieto-Fernandez FE, Ruiz A, Ntukogu N, Nodimelle L, Pryor SC (2006) Short term lead exposure induces a stress-like response in adult mice. Med Sci Monit 12:BR325-BR329
38. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529
39. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
40. Peterson RE, Pierce CE (1960) The metabolism of corticosterone in man. J Clin Invest 39:741-757
41. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
42. Rodgers RJ (1997) Animal models of 'anxiety': where next? Behav Pharmacol 8:477-504
43. Rossi-George A, Virgolini MB, Weston D, Cory-Slechta DA (2009) Alterations in glucocorticoid negative feedback following maternal Pb, prenatal stress and the combination: a potential biological unifying mechanism for their corresponding disease profiles. Toxicol Appl Pharmacol 234:117-127
44. Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24(1):15-45
45. Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ (1997) 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology (Berlin) 133:309-312
46. Sen D, Wolfson H, Dilworth M (2002) Lead exposure in scaffolders during refurbishment construction activity - an observational study. Occup Med (Lond) 52:49-54
47. Smith SM, Vale WW (2006) The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383-395
48. Szymańska M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Kubera M, Lekiewicz M, Regulska M, Lasoń W (2009) The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 34:822-832
49. van Praag HM (1986) Biological suicide research: outcome and limitations. Biol Psychiatr 21:1305-1323
50. Virgolini MB, Chen K, Weston DD, Bauter MR, Cory-Slechta DA (2005) Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci 87:469-482
51. Xu J, Yan CH, Yang B, Xie HF, Zou XY, Zhong L, Gao Y, Tian Y, Shen XM (2009) The role of metabotropic glutamate receptor 5 in developmental lead neurotoxicity. Toxicol Lett 191:223-230
52. Young SN, Chouinard G, Annable L (1981) Tryptophan in the treatment of depression. Adv Exp Med Biol 133:727-737